[Federal Register: October 25, 1999 (Volume 64, Number 205)]
[Notices]               
[Page 57474]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25oc99-76]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung and Blood Institute 
Special Emphasis Panel, Family Blood Pressure Program.
    Date: November 3-4, 1999.
    Time: November 3, 1999, 7 p.m. to 9 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Bethesda, 8120 Wisconsin Ave, Bethesda, MD 
20814.

    Time: November 4, 1999, 8:00 am to 4:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Bethesda, 8120 Wisconsin Ave, Bethesda, MD 
20814.
    Contact Person: Valerie L. Prenger, PhD, Health Science 
Administrator, NIH, NHLBI, DEA, Review Branch, Rockledge Center II, 
6701 Rockledge Drive, Suite 7198, Bethesda, MD 20892-7924, (301) 
435-0297.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated October 18, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-27807 Filed 10-22-99; 8:45 am]
BILLING CODE 4140-01-M